Class effect of beta-blockers in survivors of ST-elevation myocardial infarction: A nationwide cohort study using an insurance claims database

Scientific Reports
Ting-Tse LinMei-Shu Lai

Abstract

Beta-blockers can help reduce mortality following acute myocardial infarction (MI); however, whether beta-blockers exert a class effect remains controversial. This study identified all patients with first ST-elevation MI for the period of 2003 to 2010 from the National Health Insurance claims database, Taiwan. We compared patients prescribed carvedilol, bisoprolol, and propranolol. Study outcomes included all-cause death, cardiovascular death, and recurrence of MI. The propensity scores were constructed using multinomial logistic regression to model the receipt of different beta-blockers. Treating carvedilol group as a reference, we employed a simultaneous three-group comparison approach using the Cox regression model with adjustment for the propensity scores to compare the relative risks of various outcomes. Among the 16836 patients, 7591 were prescribed carvedilol, 5934 bisoprolol, and 3311 propranolol. Mean follow-up time was one year. After accounting for baseline differences, patients treated with bisoprolol (HR 0.87, 95% CI 0.72-1.05, p = 0.14) or propranolol (HR 1.07, 95% CI 0.84-1.36, p = 0.58) had a similar risk of all-cause death in comparison with carvedilol. No significant differences were observed among three beta-...Continue Reading

References

Mar 26, 1982·JAMA : the Journal of the American Medical Association
Mar 1, 1997·Progress in Cardiovascular Diseases·J B SorianoD E Grobbee
Jun 25, 1999·BMJ : British Medical Journal·N FreemantleJ Harrison
Oct 8, 1999·Lancet·C D FurbergB M Psaty
Jun 27, 2002·Clinical Pharmacokinetics·William H Frishman, Mamata Alwarshetty
May 18, 2004·Journal of the American College of Cardiology·Steven J KernisCindy L Grines
Aug 4, 2004·European Heart Journal·José López-SendónUNKNOWN Task ForceOn Beta-Blockers of the European Society of Cardiology
Apr 14, 2006·The Journal of Pharmacology and Experimental Therapeutics·Ruijuan WangMasunori Matsuzaki
Jan 24, 2007·American Heart Journal·Stéphane RinfretLouise Pilote
Jan 24, 2008·Circulation·Ralph B D'AgostinoWilliam B Kannel
Nov 13, 2008·Circulation·Pardeep S Jhund, John J V McMurray
Nov 30, 2010·Journal of Cardiac Failure·Sanjoy BhattacharyaEvan Adelstein
Aug 28, 2012·European Heart Journal·UNKNOWN Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)Doron Zahger
Oct 4, 2012·JAMA : the Journal of the American Medical Association·Sripal BangaloreUNKNOWN REACH Registry Investigators
Dec 12, 2012·The American Journal of Cardiology·Daisaku NakataniUNKNOWN Osaka Acute Coronary Insufficiency Study (OACIS) Investigators
Jan 8, 2013·The American Journal of Cardiology·James J DiNicolantonioJames H O'Keefe
Jun 12, 2013·Journal of the American College of Cardiology·Clyde W YancyUNKNOWN American Heart Association Task Force on Practice Guidelines
Sep 12, 2013·Circulation. Cardiovascular Quality and Outcomes·M Alan BrookhartTil Stürmer
Nov 20, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Hsu-Wen ChouK Arnold Chan

❮ Previous
Next ❯

Methods Mentioned

BETA
coronary artery bypass

Software Mentioned

SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.